Recently, some reports show that one lncRNA MIR22HG suppresses the cell progression in several cancer, such as cholangiocarcinoma [18], hepatocellular carcinoma [19], gastric cancer [20], and lung cancer [21]. Here, MIR22HG is linked to cholangiocarcinoma.